2
|
O'Connor E, Iatropoulou D, Hashimoto S, Takahashi S, Ho DH, Greenwell T. Urethral diverticulum carcinoma in females-a case series and review of the English and Japanese literature. Transl Androl Urol 2018; 7:703-729. [PMID: 30211061 PMCID: PMC6127536 DOI: 10.21037/tau.2018.07.08] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The aims of our study were to describe our case series of three urethral diverticulum carcinomas (UDC) in women and to review the literature on UDC in females to determine patient characteristics, presenting symptoms and outcomes along with optimal investigations and treatment modalities. A literature search was performed utilizing Medline, EMBASE and the Cochrane library for all papers including case reports on UDC in women published to date. The results along with those of our three cases are detailed. A total of 126 cases of UDC in women have been reported; 75% adenocarcinoma (Adenoca), 15% transitional cell carcinoma (TCC) and 10% squamous cell carcinoma (SCC). Median age at presentation was 53 years (range, 14-81 years). The commonest presenting symptoms were bleeding and retention. Cystoscopy, MRI and trans-urethral biopsy were the commonest methods of diagnosis. Treatment was radiotherapy +/- chemotherapy alone in 21%, local excision +/- radiotherapy in 44%, urethrectomy in 3% and anterior exenteration +/- radiotherapy in 32%. At last follow-up 63% were alive and well, 10% were alive with recurrent cancer and 25% had died from their disease. UDC is rare in women. It is predominantly adenocarcinoma. There is no established treatment and survival is at best moderate. An international registry and consensus on management is needed if this is to be improved.
Collapse
Affiliation(s)
- Eabhann O'Connor
- Department of Urology, University College London Hospitals, London, UK
| | | | - Sho Hashimoto
- Department of Urology, Nihon University Itabashi Hospital, Tokyo, Japan
| | - Satoru Takahashi
- Department of Urology, Nihon University Itabashi Hospital, Tokyo, Japan
| | | | - Tamsin Greenwell
- Department of Urology, University College London Hospitals, London, UK
| |
Collapse
|
3
|
Zeng J, Wang S, Zhong L, Huang Z, Zeng Y, Wu S, Zheng D, Zou W, Lai H. Unusual Features of Clear Cell Adenocarcinoma of the Female Urethra: A Case Report and Literature Review. J Clin Med Res 2018; 10:665-667. [PMID: 29977425 PMCID: PMC6031250 DOI: 10.14740/jocmr3500w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Accepted: 06/04/2018] [Indexed: 01/03/2023] Open
Abstract
Background There has been scarce information about clear cell adenocarcinoma of the urethra (CCAU), an extremely rare type of cancer. A few case reports show that CCAU tends to have similar clinical manifestation to the other urethral carcinomas, urethrocystoscopy can easily identify tumoral lesions in the urethra, and bloody drainage from the urethral meatus is often seen during physical exams. Methods A 52-year-old woman presented with dysuria for 6 months. Urethrocystoscopy did not reveal abnormality, and there was no bloody vaginal drainage or bloody drainage from the urethral meatus during physical exams. Ultrasonography demonstrated a solid mass with well-defined margins located between the anterior vaginal wall and the posterior urethral wall. Computed tomography showed the mass with smooth margins at the level of vaginal fornix, and magnetic resonance imaging showed the same location of the tumor as ultrasonography. Results Surgical removal of the tumor was successfully performed and histological and immunohistochemical analysis confirmed the final diagnosis of CCAU. Conclusion Abnormality in urethrocystoscopy and bloody drainage during the physical exam were not found in this case, which is in contrast to the findings reported in literature. These unusual features add new knowledge about CCAU that deserves dissemination for improved CCAU diagnosis and management.
Collapse
Affiliation(s)
- Jianfeng Zeng
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Shanyun Wang
- Department of Obstetrics and Gynecology, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Liang Zhong
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Zhifeng Huang
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Ye Zeng
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Song Wu
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Dongxiang Zheng
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| | - Weiwei Zou
- Department of Anesthesiology, Zhongshan Torch Development Zone Hospital, Zhongshan City, China
| | - Haibiao Lai
- Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan affiliated with Guangzhou University of Chinese Medicine, Zhongshan City, China
| |
Collapse
|
4
|
Clear cell adenocarcinoma of the urethra: review of the literature. Int J Surg Oncol 2015; 2015:790235. [PMID: 25685552 PMCID: PMC4320870 DOI: 10.1155/2015/790235] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2014] [Revised: 10/24/2014] [Accepted: 11/25/2014] [Indexed: 02/03/2023] Open
Abstract
Background. Clear cell adenocarcinoma of the urethra (CCAU) is extremely rare and a number of clinicians may be unfamiliar with its diagnosis and biological behaviour. Aims. To review the literature on CCAU. Methods. Various internet databases were used. Results/Literature Review. (i) CCAU occurs in adults and in women in the great majority of cases. (ii) It has a particular association with urethral diverticulum, which has been present in 56% of the patients; is indistinguishable from clear cell adenocarcinoma of the female genital tract but is not associated with endometriosis; and probably does not arise by malignant transformation of nephrogenic adenoma. (iii) It is usually, readily distinguished from nephrogenic adenoma because of greater cytological a-typicality and mitotic activity and does not stain for prostate-specific antigen or prostatic acid phosphatase. (iv) It has been treated by anterior exenteration in women and cystoprostatectomy in men and at times by radiotherapy; chemotherapy has rarely been given. (v) CCAU is aggressive with low 5-year survival rates. (vi) There is no consensus opinion of treatment options that would improve the prognosis. Conclusions. Few cases of CCAU have been reported. Urologists, gynaecologists, pathologists, and oncologists should report cases of CCAU they encounter and enter them into a multicentric trial to determine the best treatment options that would improve the prognosis.
Collapse
|
5
|
Shidham VB, DeMay RM. Thank you CytoJournal reviewers for your 2012 and 2013 services! Cytojournal 2014. [PMCID: PMC4007383 DOI: 10.4103/1742-6413.129186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- Vinod B. Shidham
- Address: Department of Pathology, Wayne State University School of Medicine, Karmanos Cancer Center and Detroit Medical Center, Detroit, MI 48201, USA
| | - Richard M. DeMay
- Department of Pathology, University of Chicago, Chicago, IL, USA
| |
Collapse
|
6
|
Mehra R, Vats P, Kalyana-Sundaram S, Udager AM, Roh M, Alva A, Pan J, Lonigro RJ, Siddiqui J, Weizer A, Lee C, Cao X, Wu YM, Robinson DR, Dhanasekaran SM, Chinnaiyan AM. Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. THE AMERICAN JOURNAL OF PATHOLOGY 2014; 184:584-91. [PMID: 24389164 PMCID: PMC3936309 DOI: 10.1016/j.ajpath.2013.11.023] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2013] [Revised: 10/18/2013] [Accepted: 11/19/2013] [Indexed: 12/11/2022]
Abstract
Primary clear-cell adenocarcinoma of the urethra, a rare tumor that histomorphologically resembles clear-cell carcinoma of the female genital tract, occurs predominantly in women and is associated with a relatively poor prognosis. The histogenesis of this rare urethral neoplasm has not been completely resolved, but it is thought to arise from either müllerian rests or metaplastic urothelium. Herein, we present comprehensive surgical pathological and cytopathological findings from a patient with primary urethral clear-cell adenocarcinoma and describe next-generation sequencing results for this patient's unique tumor-the first such reported characterization of molecular aberrations in urethral clear-cell adenocarcinoma at the transcriptomic and genomic levels. Transcriptome analysis revealed novel gene fusion candidates, including ANKRD28-FNDC3B. Whole-exome analysis demonstrated focal copy number loss at the SMAD4 and ARID2 loci and 38 somatic mutations, including a truncating mutation in ATM and a novel nonsynonymous mutation in ALK.
Collapse
Affiliation(s)
- Rohit Mehra
- Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan.
| | - Pankaj Vats
- Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | - Shanker Kalyana-Sundaram
- Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | - Aaron M Udager
- Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan
| | - Michael Roh
- Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan
| | - Ajjai Alva
- Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan; Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan
| | - Jincheng Pan
- Michigan Center for Translational Pathology, Ann Arbor, Michigan; Department of Urology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
| | - Robert J Lonigro
- Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | - Javed Siddiqui
- Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | - Alon Weizer
- Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan
| | - Cheryl Lee
- Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan
| | - Xuhong Cao
- Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | - Yi-Mi Wu
- Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | - Dan R Robinson
- Michigan Center for Translational Pathology, Ann Arbor, Michigan
| | | | - Arul M Chinnaiyan
- Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan; Howard Hughes Medical Institute, Ann Arbor, Michigan
| |
Collapse
|
7
|
Shidham VB, Demay RM. Announcement of first time Cytojournal impact factor for 2012 coincides with Cytojournal decade celebration (2004-2013). Cytojournal 2013; 10:18. [PMID: 24082914 PMCID: PMC3779425 DOI: 10.4103/1742-6413.117359] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2013] [Accepted: 07/29/2013] [Indexed: 12/25/2022] Open
Affiliation(s)
- Vinod B Shidham
- Address: Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA
| | | |
Collapse
|